Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 2
2012 1
2013 1
2014 1
2016 1
2017 2
2019 1
2021 2
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
The effect of erenumab on brain network function in episodic migraine patients: a randomized, placebo-controlled clinical trial (RESET BRAIN).
Filippi M, Messina R, Bartezaghi M, Cetta I, Colombo B, Grazzi L, Martinelli D, Ornello R, Pichiecchio A, Raimondi D, Russo A, Sacco S, Splendiani A, Tassorelli C, Turrini R, Valsasina P, Rocca MA; RESET BRAIN Study Group. Filippi M, et al. Among authors: turrini r. J Neurol. 2023 Nov;270(11):5600-5612. doi: 10.1007/s00415-023-11879-9. Epub 2023 Aug 8. J Neurol. 2023. PMID: 37550498 Free PMC article. Clinical Trial.
Rationale for Use of Sphingosine-1-Phosphate Receptor Modulators in COVID-19 Patients: Overview of Scientific Evidence.
Hach T, Shakeri-Nejad K, Bigaud M, Dahlke F, de Micco M, Petricoul O, Graham G, Piani-Meier D, Turrini R, Brinkmann V, Nicoletti F. Hach T, et al. Among authors: turrini r. J Interferon Cytokine Res. 2023 Jun;43(6):246-256. doi: 10.1089/jir.2022.0078. Epub 2022 Nov 29. J Interferon Cytokine Res. 2023. PMID: 36454249 Free PMC article. Review.
Unmet needs and gaps in the identification of secondary progression in multiple sclerosis: a Southern Italy healthcare professionals' perspective.
Lus G, Bassano MA, Brescia Morra V, Bonavita S, Gallo A, Maimone D, Malerba L, Maniscalco GT, Saccà F, Salemi G, Turrini R, Cottone S, Sessa E, Buccafusca M, Grimaldi LME. Lus G, et al. Among authors: turrini r. Neurol Sci. 2023 Jan;44(1):45-58. doi: 10.1007/s10072-022-06402-3. Epub 2022 Sep 17. Neurol Sci. 2023. PMID: 36114980 Free PMC article. Review.
Narrative Medicine to integrate patients', caregivers' and clinicians' migraine experiences: the DRONE multicentre project.
Tonini MC, Fiorencis A, Iannacchero R, Zampolini M, Cappuccio A, Raddino R, Grillo E, Albanese M, Allais G, Bassano MA, Brighina F, Carboni T, Frediani F, Grazzi L, Mastrandrea C, Moschiano F, Poeta MG, Ranieri A, Turrini R, Marini MG. Tonini MC, et al. Among authors: turrini r. Neurol Sci. 2021 Dec;42(12):5277-5288. doi: 10.1007/s10072-021-05227-w. Epub 2021 Apr 15. Neurol Sci. 2021. PMID: 33856582 Free PMC article.
Fingolimod protects cultured cortical neurons against excitotoxic death.
Di Menna L, Molinaro G, Di Nuzzo L, Riozzi B, Zappulla C, Pozzilli C, Turrini R, Caraci F, Copani A, Battaglia G, Nicoletti F, Bruno V. Di Menna L, et al. Among authors: turrini r. Pharmacol Res. 2013 Jan;67(1):1-9. doi: 10.1016/j.phrs.2012.10.004. Epub 2012 Oct 13. Pharmacol Res. 2013. PMID: 23073075
Description and preliminary experience with Virtual Visit Assessment (ViVA) during the COVID-19 pandemic, a structured virtual management protocol for patients with multiple sclerosis.
Bergamaschi R, Tronconi L, Bosone D, Mastretti A, Jommi L, Bassano MA, Turrini R, Benati S, Volpe M, Franzini JM, Allodi S, Mallucci G. Bergamaschi R, et al. Among authors: turrini r. Neurol Sci. 2022 Feb;43(2):1207-1214. doi: 10.1007/s10072-021-05371-3. Epub 2021 Jun 15. Neurol Sci. 2022. PMID: 34131815 Free PMC article.
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod.
Vanoli E, Montano N, De Angelis G, Badilini F, Mirabella M, Bonavita S, Patti F, Bianco A, Sparaco M, Chisari C, Laroni A, Frigerio F, Bartezaghi M, Rossi S, Turrini R, Mancardi G. Vanoli E, et al. Among authors: turrini r. J Neurol Sci. 2019 Oct 15;405:116423. doi: 10.1016/j.jns.2019.116423. Epub 2019 Aug 8. J Neurol Sci. 2019. PMID: 31520869 Free article.
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing-remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study).
Comi G, Patti F, Rocca MA, Mattioli FC, Amato MP, Gallo P, Centonze D, Pozzilli C, Saccà F, Bergh FT, Bartezaghi M, Turrini R, Filippi M; Golden Study Group. Comi G, et al. Among authors: turrini r. J Neurol. 2017 Dec;264(12):2436-2449. doi: 10.1007/s00415-017-8642-5. Epub 2017 Oct 23. J Neurol. 2017. PMID: 29063244 Free PMC article. Clinical Trial.
14 results